{
    "Trade/Device Name(s)": [
        "CareSens Blood Glucose Monitoring System",
        "CareSens II Meter",
        "CareSens POP Meter",
        "CareSens Test Strips",
        "CareSens Control Solution (Normal and Middle ranges)"
    ],
    "Submitter Information": "i-SENS, Inc.",
    "510(k) Number": "K080923",
    "Predicate Device Reference 510(k) Number(s)": [
        "K024194"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "August 25, 2008",
    "Summary Letter Received Date": "August 25, 2008",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "tdm"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "CareSens II Meter",
        "CareSens POP Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Glucose oxidase method",
        "Amperometric measurement",
        "Electrochemical detection"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Meter",
        "Test Strip",
        "Control Solution",
        "Lancing Device",
        "Lancet"
    ],
    "Document Summary": "FDA 510(k) summary for CareSens Blood Glucose Monitoring System for quantitative measurement of glucose in capillary whole blood using glucose oxidase and amperometric detection.",
    "Indications for Use Summary": "For quantitative measurement of glucose level in capillary whole blood as an aid in monitoring diabetes management at home or in clinical settings; in vitro diagnostic use only; testing sites include fingertip, forearm, palm, thigh, and calf.",
    "fda_folder": "Clinical Chemistry"
}